To evaluate risk factor profiles associated with clinically significant pulmonary hemorrhage (PH) in preterm (PT) and term infants.
mature infants and infants with severe intrauterine growth restriction, the incidence is as high as 50 per 1000 live births. 2 With recent improvements in the survival of increasingly immature infants and the observation that exogenous surfactant treatment might be associated with increased risk of PHs, 3 there has been renewed interest in this potentially life-threatening respiratory complication. In very low birth weight infants, severe PH markedly increases the risk of death or chronic lung disease, 4 but does not significantly affect long-term neurodevelopmental outcome in survivors. 4, 5 The pathogenesis of PH is unknown.
We initiated this study in an effort to identify risk factors associated with PH, with the ultimate aims of contributing to the understanding of the pathogenesis of PH and identifying preventive strategies.
METHODS
We conducted a case-control study of clinically significant PHs among infants admitted to the neonatal intensive care units (NICUs) of the Joint Program in Neonatology in Boston, MA. The study was approved by the Institutional Review Boards of each participating hospital. Eligible infants were born over an 8-year period (1987 to 1994) and were admitted to NICUs at one of three hospitals: Children's Hospital, Brigham and Women's Hospital, and Beth Israel Hospital (all in Boston, MA). The study period spans three different eras of surfactant use at these institutions: the presurfactant era (1987 to 1989), a 4-year period of surfactant replacement therapy with a synthetic surfactant (Exosurf Neonatal (dipalmitoylphosphatidyllcholine, hexadecanol, tyloxapol)) (1990 to 1993), and a period during which a natural surfactant (Survanta (beractant)) was used to treat respiratory distress syndrome (after 1994). Surfactant was administered to infants hospitalized in the study NICUs using a rescue strategy.
We defined PH as the presence of hemorrhagic fluid in the trachea accompanied by respiratory decompensation requiring increased respiratory support (i.e., an FIO 2 increase of Ͼ10%, any increase in peak inspiratory pressure, and any increase in positive end expiratory pressure) or intubation within 60 minutes of the appearance of the hemorrhagic fluid. All subjects were identified using the list of NICU diagnoses maintained in the Joint Program in Neonatology database. Medical records of potential cases were reviewed by the principal investigator (T. M. B.) to confirm that the episodes of PH fulfilled the above criteria. A total of 76 cases of PH were identified from the population of admissions over the 8-year period. A total of 152 control Original Article
infants from the study NICUs were matched with the index cases by birth year and within a 200-gm birth weight range. Because our study aim was to identify antecedents of PH, data collection focused on the clinical course before the occurrence of the hemorrhage. Data for matched controls were collected for identical time periods or until NICU discharge, whichever came first.
Clinical data collected incorporated information regarding maternal and infant demographics, complications of pregnancy, labor, and delivery. Initial disease severity was assessed using physiological data of the first 24 postnatal hours to calculate the score for acute neonatal physiology (SNAP-1). 6 Disease severity was again computed for the 24-hour time period immediately preceding the first PH episode (SNAP-2). If PH occurred before 24 hours of age, only one SNAP value was recorded. For infants who received surfactant replacement therapy, the brand of surfactant and the number of doses given were noted. Diagnoses, complications, and therapies relevant to the respiratory, cardiovascular, and central nervous systems were evaluated. Respiratory and hemodynamic parameters were abstracted from nursing and respiratory flow sheets. For infants who died during their NICU stay, we attempted to determine whether PH was the precipitating cause of death.
Univariate analyses were performed using the Fisher's exact test for categorical data and the Wilcoxon rank sum test to compare median values. Variables related to PH with a p value of Ͻ0.30 and variables of prior interest, regardless of statistical significance were selected as potential candidates for multivariate analyses. Multivariate logistic regression analyses were conducted using Stata statistical software, Release 5 (Stata Corporation, College Station, TX), in a step-down modeling procedure using the likelihood ratio test to achieve the model with the smallest number of statistically significant variables. To assess the extent to which illness severity influenced the variables in the models, SNAP scores were introduced into the models, after determining the best models.
RESULTS
Over an 8-year-period (1987 to 1994), 76 cases of PH were identified. Gestational age (GA)-specific prevalence showed a bimodal distribution. Therefore, we chose to conduct separate analyses for each GA group: infants born at Յ34 weeks' gestation were analyzed as preterm (PT) infants, and infants born at Ͼ34 weeks' gestation were considered near-term/full-term (NT/FT) infants. A total of 50 cases of PH occurred among PT infants for whom the median GA was 27 weeks and the median birth weight was 943 gm. There were 26 cases among the NT/FT infants whose median GA was 38.5 weeks and median birth weight was 3103 gm (Table 1) .
Mortality rates were 38% and 23% for the PT cases the NT/FT cases, respectively. PH was considered to be the principal cause of death in 27% of the fatal PT cases and 17% of the fatal NT/FT cases. PH was also judged to be an important contributing factor to mortality in an additional 53% of fatal PT cases and 17% of fatal NT/FT cases.
PH occurred later among PT infants on average than among NT/FT infants. The median age at the time of the first PH was 46 hours in PT infants compared with only 6 hours in NT/FT infants ( Figure) . Nine PT infants had more than one episode of PH, compared with only one infant in the NT/FT group who had recurrent hemorrhage. Before the PH, 42% of PT infants received Exosurf and 20% received Survanta. Neither the type of surfactant nor the number of doses contributed significantly to PH risk after adjusting for other factors in the multivariate analyses. However, study power to evaluate the hypothesis that surfactant treatment was associated with PH risk was low (0.52).
The NT/FT cases had higher SNAP-1 scores than their controls. In contrast, SNAP-1 scores did not differ between cases and controls in the PT group. However, PT case infants showed no improvement in SNAP scores over time. This was demonstrated by higher SNAP-2 scores among PT cases than among their matched control subjects ( Table 2) .
We conducted logistic regression multivariate modeling separately for each GA group both with and without SNAP as an indicator of severity of illness. A number of antenatal, perinatal, and neonatal factors were considered as potential confounding factors. In each of the four models, we tested the candidate confounding factors in a step-down approach to achieve the most parsimonious model for each GA group (Table 3) .
PT Infants
Among the group of subjects born at Յ34 weeks' gestation, a variable for the youngest gestations (24 to 26 weeks' gestation) was entered in the logistic regression model to provide an additional adjustment for biologic immaturity. The most parsimonious model included three LGA, large for GA.
additional factors: antenatal glucocorticoid treatment, delivery room resuscitation with positive pressure ventilation, and a platelet count of Ͻ100,000 ϫ 10 6 /liter before the PH. Maternal receipt of a complete course of antenatal glucocorticoids was associated with a reduced risk of PH compared with those whose mothers received none or a partial course. After adjusting for all other variables in the model, a fourfold increased risk was associated with both thrombocytopenia and the need for positive pressure ventilation during delivery room resuscitation. In models including SNAP, scores of Ն24 were associated with five times the risk of PH; scores of 17 to 23 conferred twice the risk, compared with scores of Ͻ17. The addition of SNAP to the model did not change the odds ratio (OR) for antenatal glucocorticoid therapy and only slightly reduced the ORs for thrombocytopenia and positive pressure ventilation.
NT/FT Infants
The most parsimonious logistic regression model for the subjects born at Ͼ34 weeks' gestation included three variables: meconium aspiration, hypotension, and delivery room resuscitation with positive pressure ventilation. Each of these factors was associated with increased risk of PH: meconium aspiration increased the risk fivefold, and infants with hypotension or resuscitation with positive pressure ventilation had three times the risk for PH compared with those without each risk factor. Adjustment for SNAP category had a modest effect on the ORs for meconium aspiration and resuscitation with positive pressure ventilation. However, adjusting for SNAP category was associated with a reduction in the OR for hypotension from 3.5 to 2.0. A prehemorrhage SNAP score of Ն24 was associated with a fivefold increase in the risk of PH, and SNAP scores of 17 to 23 were associated with a doubling of PH risk, compared with infants whose SNAP scores were Ͻ17.
DISCUSSION
Case series and autopsy reports, as summarized by Fekete and Nemeth, 7 have correlated neonatal PH with a number of conditions, including perinatal asphyxia, surfactant deficiency, pneumonia, hypothermia, septicemia, coagulation disorders, congenital heart disease, central nervous system lesions, and oxygen toxicity. Other authors have extended the list of possible causes to include aspiration of maternal blood, 8 intrathoracic gastrogenic cysts, 9 intravenous administration of hyperosmolar solutions, 10 diffuse pulmonary embolism with drug microaggregates, 11 and urea cycle defects accompanied by hyperammonemia. 12, 13 In separate reports Adamson et al. 14 and Cole et al. 15 showed that the lung effluents of infants with PH had low hematocrits and contained only small molecular weight plasma proteins. They concluded that the lung effluent in most cases of neonatal PH is hemorrhagic edema rather than whole blood. 15 Because most of their patients suffered some degree of perinatal asphyxia, Cole et al. 15 speculated that left ventricular failure with a subsequent increase in pulmonary capillary pressure was the most important precipitating factor. Almost 20 years later, West et al. 16 observed that alveolar overdistension combined with high pulmonary capillary pressure caused breaks in the epithelial/endothelial barrier, resulting in leakage of hemorrhagic edema fluid into the air spaces. They identified the major forces involved in what they termed stress failure of pulmonary capillaries to be: (1) circumferential tension in the capillary wall resulting from the capillary transmural pressure, (2) surface tension of the alveolar lining layer, which acts to support the bulging capillary wall, and (3) longitudinal tension of tissue elements in the alveolar wall associated with inflation of the lung. 16 They showed that stress failure of pulmonary capillaries is the likely mechanism causing high-permeability pulmonary edema, which is typical of neurogenic pulmonary edema, 17 high-altitude pulmonary edema, 18 and even exercise-induced PH observed in race horses. 19 We speculate that stress failure of pulmonary capillaries might play a role in the pathogenesis of PH in the newborn infant.
In the majority of our PT cases, PH occurred at the end of the second postnatal day (median age 46 hours), closely matching the observation made by Tomaszewska et al. 5 in a study of 58 very low birth weight infants with PH (median age 40 hours). The need for delivery room resuscitation with positive pressure ventilation in this group of patients is likely a marker of perinatal depression, lung disease, or extreme immaturity. Mechanical ventilation with its inherent risk of alveolar overdistension might contribute to stress failure of pulmonary capillaries by adding pulmonary capillary wall stress through tension on tissue elements in the alveolar wall. 16 Among our PT study subjects, antenatal glucocorticoid therapy and a very immature GA were associated with reduced risk of PH. Glucocorticoid-induced surfactant production 20 and reduced capillary permeability 21 might explain this observation. In a rat model of highaltitude pulmonary edema, a dexamethasone-induced reduction in transvascular protein leak appeared to be independent of pulmonary artery pressure. 22 It is conceivable that glucocorticoids induce vascular structural or biochemical changes that make pulmonary capillaries less susceptible to stress failure. The apparent protective influence on PH of a very young GA is more challenging to explain. Selective pre-PH mortality of the infants who were most immature and critically ill might explain this observation. Another possibility is that the immature infant's incomplete pulmonary alveolarization, accompanied by wide interstitial spaces, reduces the transfer of hemorrhagic pulmonary edema to air spaces, thus reducing the likelihood of clinical detection.
In our study, surfactant replacement therapy, either with Exosurf or Survanta, did not increase the risk of clinically significant PH. In a 1993 meta-analysis of 11 surfactant trials that collected data on the occurrence of PH prospectively, Raju and Langenberg 3 reported a pooled estimate of relative risk for PH with any surfactant therapy of 1.47 (95% confidence interval (CI) of 1.05 to 2.07; p Ͻ 0.05). This finding resulted from a significant increase in PHs in trials in which synthetic surfactants were used in a prevention strategy. 3 Data from more recent prospective randomized placebo-controlled surfactant trials confirmed these observations. [23] [24] [25] Because our study NICUs used only a rescue strategy for surfactant treatment, our observation that surfactant replacement therapy did not increase the risk of clinically significant PH is consistent with prior studies.
Among NT/FT infants, PH occurs shortly after birth: the majority of our patients in this category developed PH only 6 hours after birth. Therefore, it is likely that PH among these infants is influenced by factors operating in the antenatal and immediate perinatal periods. The risk factors identified by the multivariate analyses are more common after intrauterine hypoxia. An association between meconium aspiration and PH has been described previously. 26, 27 Meconium aspi- SNAP scores were used to ensure that the variables predicting PH did not simply reflect sicker infants. Although some variables did not attain nominal statistical significance when SNAP was added to the model, the ORs remained elevated, suggesting the variables predict more than severity of illness. Of note, for NT/FT infants, PH was more likely to occur in the first 24 hours. Therefore, only SNAP-1 was evaluated.
In summary, PH occurs in both PT and NT/FT newborn infants. PH in PT infants occurs later and is associated with a higher mortality rate than PH in NT/FT infants. Results of the multivariate logistic regression analyses identified distinct risk factor profiles for the two GA categories. Among PT infants, antenatal glucocorticoids were found to be protective, whereas the need for delivery room resuscitation with positive pressure ventilation and thrombocytopenia were associated with increased risk of PH. Stress failure of pulmonary capillaries resulting from increased wall stress associated with alveolar overinflation, in some instances exaggerated by a bleeding diathesis due to thrombocytopenia, might explain this observation. Among NT/FT infants, meconium aspiration, need for delivery room resuscitation with positive pressure ventilation, and systemic hypotension were significant risk factors. We speculate that, among the NT/FT infants, pulmonary hypertension and myocardial dysfunction after intrauterine hypoxia elevate pulmonary capillary pressure, causing stress failure and intra-alveolar hemorrhage. Recognition of the distinct risk profiles may help to develop better preventative and therapeutic strategies among PT and NT/FT infants at risk of developing PH. The finding of a protective effect of antenatal glucocorticoid therapy offers yet another argument for uniform administration of antenatal glucocorticoids in threatened premature deliveries.
